Translations:Biosimilar/34/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
14,847 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 09:54, 20 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Biosimilar)
{| class="wikitable"
|-
! Date of Biosimilar FDA Approval !! Biosimilar Product !! Original Product
|-
| March 2015 || filgrastim-sndz/Zarxio || [[filgrastim]]/Neupogen
|-
| April 2016 || infliximab-dyyb/Inflectra || [[infliximab]]/Remicade
|-
| August 2016 || etanercept-szzs/Erelzi || [[etanercept]]/Enbrel
|-
| September 2016 || adalimumab-atto/Amjevita || [[adalimumab]]/Humira
|-
| April 2017 || infliximab-abda/Renflexis || [[infliximab]]/Remicade
|-
| August 2017 || adalimumab-adbm/Cyltezo || [[adalimumab]]/Humira
|-
| September 2017 || bevacizumab-awwb/Mvasi || [[bevacizumab]]/Avastin
|-
| December 2017 || trastuzumab-dkst/Ogivri || [[trastuzumab]]/Herceptin
|-
| December 2017 || infliximab-qbtx/Ixifi || [[infliximab]]/Remicade
|-
| May 2018 || epoetin alfa-epbx/Retacrit || [[epoetin alfa]]/Procrit
|-
|June 2018 || pegfilgrastim-jmdb/Fulphila || [[pegfilgrastim]]/Neulasta
|-
| July 2018 || filgrastim-aafi/Nivestym || [[filgrastim]]/Neupogen
|-
| October 2018 || adalimumab-adaz/Hyrimoz || [[adalimumab]]/Humira
|-
| November 2018 || pegfilgrastim-cbqv/Udenyca || [[pegfilgrastim]]/Neulasta
|-
| November 2018 || rituximab-abbs/Truxima || [[rituximab]]/Rituxan
|-
| December 2018 || trastuzumab-pkrb/Herzuma || [[trastuzumab]]/Herceptin
|-
| January 2019 || trastuzumab-dttb/Ontruzant || [[trastuzumab]]/Herceptin
|-
| March 2019 || trastuzumab-qyyp/Trazimera || [[trastuzumab]]/Herceptin
|-
| April 2019 || etanercept-ykro/Eticovo || [[etanercept]]/Enbrel
|-
| June 2019 || trastuzumab-anns/Kanjinti || [[trastuzumab]]/Herceptin
|-
| June 2019 || bevacizumab-bvzr/Zirabev || [[bevacizumab]]/Avastin
|-
| July 2019 || rituximab-pvvr/Ruxience || [[rituximab]]/Rituxan
|-
| July 2019 || adalimumab-bwwd/Hadlima || [[adalimumab]]/Humira
|-
| November 2019 || pegfilgrastim-bmez/Ziextenzo || [[pegfilgrastim]]/Neulasta
|-
| November 2019 || adalimumab-afzb/Abrilada || [[adalimumab]]/Humira
|-
| December 2019 || infliximab-axxq/Avsola || [[infliximab]]/Remicade
|-
| June 2020 || pegfilgrastim-apgf/Nyvepria || [[pegfilgrastim]]/Neulasta
|-
| July 2020 || adalimumab-fkjp/Hulio || [[adalimumab]]/Humira
|-
| December 2020 || rituximab-arrx/Riabni || [[rituximab]]/Rituxan
|-
| July 2021|| insulin glargine-yfgn/Semglee || [[insulin glargine]]/Lantus
|-
| September 2021 || ranibizumab-nuna/Byooviz || [[ranibizumab]]/Lucentis
|-
| December 2021 || insulin glargine-aglr/Rezvoglar || [[insulin glargine]]/Lantus
|-
| December 2021 || adalimumab-aqvh/Yusimry || [[adalimumab]]/Humira
|-
| February 2022 || filgrastim-ayow/Releuko || [[filgrastim]]/Neupogen
|-
| April 2022 || bevacizumab-maly/Alymsys || [[bevacizumab]]/Avastin
|-
| May 2022 || pegfilgrastim-pbbk/Fylnetra || [[pegfilgrastim]]/Neulasta
|-
| August 2022 || ranibizumab-eqrn/Cimerli || [[ranibizumab]]/Lucentis
|-
| September 2022|| pegfilgrastim-fpgk/Stimufend || [[pegfilgrastim]]/Neulasta
|-
| September 2022 || bevacizumab-adcd/Vegzelma || [[bevacizumab]]/Avastin
|-
| December 2022 || adalimumab-aacf/Idacio || [[adalimumab]]/Humira
|-
| May 2023 || adalimumab-aaty/Yuflyma || [[adalimumab]]/Humira
|-
| August 2023 || natalizumab-sztn/Tyruko || [[natalizumab]]/Tysabri
|-
| September 2023 || tocilizumab-bavi/Tofidence || [[tocilizumab]]/Actemra
|-
| October 2023 || ustekinumab-auub/Wezlana || [[ustekinumab]]/Stelara
|-
| December 2023 || bevacizumab-tnjn/Avzivi || [[bevacizumab]]/Avastin
|-
| February 2024 || adalimumab-ryvk/Simlandi || [[adalimumab]]/Humira
|-
| March 2024 || denosumab-bbdz/Jubbonti || [[denosumab]]/Prolia
|-
| March 2024 || denosumab-bbdz/Wyost || [[denosumab]]/Xgeva
|}
Date of Biosimilar FDA Approval Biosimilar Product Original Product
March 2015 filgrastim-sndz/Zarxio filgrastim/Neupogen
April 2016 infliximab-dyyb/Inflectra infliximab/Remicade
August 2016 etanercept-szzs/Erelzi etanercept/Enbrel
September 2016 adalimumab-atto/Amjevita adalimumab/Humira
April 2017 infliximab-abda/Renflexis infliximab/Remicade
August 2017 adalimumab-adbm/Cyltezo adalimumab/Humira
September 2017 bevacizumab-awwb/Mvasi bevacizumab/Avastin
December 2017 trastuzumab-dkst/Ogivri trastuzumab/Herceptin
December 2017 infliximab-qbtx/Ixifi infliximab/Remicade
May 2018 epoetin alfa-epbx/Retacrit epoetin alfa/Procrit
June 2018 pegfilgrastim-jmdb/Fulphila pegfilgrastim/Neulasta
July 2018 filgrastim-aafi/Nivestym filgrastim/Neupogen
October 2018 adalimumab-adaz/Hyrimoz adalimumab/Humira
November 2018 pegfilgrastim-cbqv/Udenyca pegfilgrastim/Neulasta
November 2018 rituximab-abbs/Truxima rituximab/Rituxan
December 2018 trastuzumab-pkrb/Herzuma trastuzumab/Herceptin
January 2019 trastuzumab-dttb/Ontruzant trastuzumab/Herceptin
March 2019 trastuzumab-qyyp/Trazimera trastuzumab/Herceptin
April 2019 etanercept-ykro/Eticovo etanercept/Enbrel
June 2019 trastuzumab-anns/Kanjinti trastuzumab/Herceptin
June 2019 bevacizumab-bvzr/Zirabev bevacizumab/Avastin
July 2019 rituximab-pvvr/Ruxience rituximab/Rituxan
July 2019 adalimumab-bwwd/Hadlima adalimumab/Humira
November 2019 pegfilgrastim-bmez/Ziextenzo pegfilgrastim/Neulasta
November 2019 adalimumab-afzb/Abrilada adalimumab/Humira
December 2019 infliximab-axxq/Avsola infliximab/Remicade
June 2020 pegfilgrastim-apgf/Nyvepria pegfilgrastim/Neulasta
July 2020 adalimumab-fkjp/Hulio adalimumab/Humira
December 2020 rituximab-arrx/Riabni rituximab/Rituxan
July 2021 insulin glargine-yfgn/Semglee insulin glargine/Lantus
September 2021 ranibizumab-nuna/Byooviz ranibizumab/Lucentis
December 2021 insulin glargine-aglr/Rezvoglar insulin glargine/Lantus
December 2021 adalimumab-aqvh/Yusimry adalimumab/Humira
February 2022 filgrastim-ayow/Releuko filgrastim/Neupogen
April 2022 bevacizumab-maly/Alymsys bevacizumab/Avastin
May 2022 pegfilgrastim-pbbk/Fylnetra pegfilgrastim/Neulasta
August 2022 ranibizumab-eqrn/Cimerli ranibizumab/Lucentis
September 2022 pegfilgrastim-fpgk/Stimufend pegfilgrastim/Neulasta
September 2022 bevacizumab-adcd/Vegzelma bevacizumab/Avastin
December 2022 adalimumab-aacf/Idacio adalimumab/Humira
May 2023 adalimumab-aaty/Yuflyma adalimumab/Humira
August 2023 natalizumab-sztn/Tyruko natalizumab/Tysabri
September 2023 tocilizumab-bavi/Tofidence tocilizumab/Actemra
October 2023 ustekinumab-auub/Wezlana ustekinumab/Stelara
December 2023 bevacizumab-tnjn/Avzivi bevacizumab/Avastin
February 2024 adalimumab-ryvk/Simlandi adalimumab/Humira
March 2024 denosumab-bbdz/Jubbonti denosumab/Prolia
March 2024 denosumab-bbdz/Wyost denosumab/Xgeva
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Biosimilar/34/en&oldid=130343"